Andrew Hykes - 19 Aug 2021 Form 4 Insider Report for Inari Medical, Inc.

Role
Chief Operating Officer
Signature
/s/ Angela Ahmad, attorney-in-fact for Andrew Hykes
Issuer symbol
N/A
Transactions as of
19 Aug 2021
Net transactions value
-$653,916
Form type
4
Filing time
19 Aug 2021, 19:43:20 UTC
Previous filing
20 Aug 2021
Next filing
17 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Sale $500,487 -6,900 -3.7% $72.53 180,274 19 Aug 2021 Direct F1, F2
transaction NARI Common Stock Sale $153,429 -2,100 -1.2% $73.06 178,174 19 Aug 2021 Direct F1, F3
holding NARI Common Stock 1,550 19 Aug 2021 By Child 1
holding NARI Common Stock1 1,550 19 Aug 2021 By Child 2
holding NARI Common Stock 1,550 19 Aug 2021 By Child 3
holding NARI Common Stock 1,000 19 Aug 2021 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.
F2 This transaction was executed in multiple trades at prices ranging from $71.92 to $72.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $72.92 to $73.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.